Login / Signup

Clinical course of psoriasis patients that discontinued biologics during the COVID-19 pandemic.

Filiz Topaloğlu DemirAlgün Polat EkinciSema AytekinZeynep TopkarcıMelek Aslan KayıranTuğba Özkök Akbulutİlteriş Oğuz TopalSezgi Sarıkaya SolakAsude Kara PolatAyşe Serap Karadağ
Published in: Journal of cosmetic dermatology (2023)
As the biologics-free period is prolonged, the likelihood of clinical worsening and relapse increases, therefore, we do not recommend discontinuing biological agents.
Keyphrases
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • chronic kidney disease
  • prognostic factors
  • peritoneal dialysis
  • patient reported outcomes
  • free survival